Search clinical trials for: HL-040XC

Total 39 results

Shanghai Kechow Pharma, Inc.

Completed

Study of HL-085 in NRAS Mutant Advanced Melanoma

Melanoma

China
Shanghai Kechow Pharma, Inc.

Completed

HL-085 in NRAS-mutated Advanced Melanoma

Melanoma

China
Kechow Pharma, Inc.

Completed

Study of HL-085 in Patients With Advanced Solid Tumor Tumors

Solid Tumor, Adult

United States
North District Hospital

Completed

Orthotics and Achilles Load in Runners

Achilles Tendinopathy | Flatfoot | Sports Injury

Hong Kong
Shanghai Kechow Pharma, Inc.

Recruiting

HL-085 in Adults With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas

Neurofibromatosis 1 | Plexiform Neurofibromas

China
LEO Pharma

Terminated

Efficacy and Safety of 3 Doses of HL10 Given at Fixed Time Intervals Compared to Standard Therapy

Acute Respiratory Distress Syndrome | Acute Lung Injury

Denmark, Belgium, Austria, Canada, Finland, France, Germany, Netherlands, Norway, Spain, Sweden, United Kingdom
Boston University
National Institute of Dental and Craniofacial Research (NIDCR)

Not yet recruiting

Texting to Reduce Human Immunodeficiency Virus (HIV) Risk

HIV Infections
HanAll BioPharma Co., Ltd.

Completed

Phase 2 Study of HL-009 Liposomal Gel to Treat Mild to Moderate Atopic Dermatitis

Mild to Moderate Atopic Dermatitis

United States
Ege University

Not yet recruiting

The Effect of Blood Flow Restriction (Bfr) Exercise on Acute Systemic Myokine Levels in Healthy Trained Men

Muscle Hypotrophy
Shanghai Kechow Pharma, Inc.

Terminated

Phase I Study of HL-085 in Patients With Advanced Solid Tumors

Solid Tumor, Adult

United States
HanAll BioPharma Co., Ltd.

Completed

Efficacy and Safety of HL-040XC in Essential Hypertension and Hyperlipidemia

Essential Hypertension | Hyperlipidemia

Korea, Republic of
WEIDONG LIU，MD

Recruiting

Comparison of Low and High Ligation With Apical Lymph Node Dissection in the Laparoscopy Rectal Cancer (PLAND)

Rectal Cancer

China
International Centre for Diarrhoeal Disease Research...
MSD Wellcome Trust Hilleman Laboratories Pvt. Ltd.

Completed

Safety and Immunogenicity of Locally Manufactured New (HL-OCV) Oral Cholera Vaccine

Cholera

Bangladesh
University of Missouri, Kansas City

Completed

MOCHI: An RCT of Mindfulness as Treatment for Chronic Pelvic Pain in AD Women (AD)

Depression | Chronic Pelvic Pain | Inflammation Pelvic

United States
Huons Co., Ltd.

Completed

Safety and Efficacy of HL Tablet in Non-alcoholic Fatty Liver Disease Patients

Non-alcoholic Fatty Liver Disease

Korea, Republic of
Universidade Federal do Triangulo Mineiro

Unknown

Fatigability and Physical Performance: Effects of Resistance Training Variables Manipulation

Aging

Brazil
IBSA Institut Biochimique SA

Completed

A Study to Evaluate the Clinical Performance and Safety of an Intra-articular Hyaluronic Acid in Knee Osteoarthritis

Knee Osteoarthritis

Poland, Germany, Italy, Belgium, Hungary
Sixth Affiliated Hospital, Sun Yat-sen University

Recruiting

Low or High Ligation of the IMA With Apical Lymph Node Dissection in Rectal Cancer Laparoscopic Surgery

Rectal Cancer

China
Universidade Federal do Triangulo Mineiro

Unknown

Effect of Resistance Training Variable Manipulation in Postmenopausal Breast Cancer Survivors.

Postmenopause | Breast Cancer Survivors

Brazil
University of Leeds

Completed

Effect of Lubricity of Food Gels on Satiation and Satiety

Appetitive Behavior

United Kingdom
Shanghai Kechow Pharma, Inc.

Recruiting

HL-085+Vemurafenib to Treat Advanced Melanoma Patients With BRAF V600E/K Mutation

Melanoma

China
Foundation for Liver Research

Withdrawn

Pancreatic Enzyme Suppletion in Pancreatic Cancer (EPC)

Adenocarcinoma of the Pancreas | Normal Pancreatic Exocrine Function

Netherlands
Shanghai Kechow Pharma, Inc.

Not yet recruiting

Efficacy and Safety of HL-085 Combined With Vemurafenib in BRAF V600E Patients With Non-small Cell Lung Cancer: a Phase II Clinical Study

Non-small-cell Lung Cancer
Shanghai Kechow Pharma, Inc.

Recruiting

A PhaseI Study of HL-085 Plus Vemurafenib in Solid Tumor With BRAF V600 Mutation

Solid Tumor

China
Shanghai Kechow Pharma, Inc.

Terminated

Study of HL-085 Plus Docetaxel in Patients With KRAS Mutant NSCLC

Nsclc

China
Asan Medical Center
HanAll BioPharma Co., Ltd.

Completed

Clinical Trial to Compare the Pharmacokinetics and Pharmacodynamics After Oral Administration of Glucophage and HL-018

Healthy

Korea, Republic of
Pirogov Russian National Research Medical University

Recruiting

Caprini Score in Venous Surgery: a Prospective Cohort Study (CAPSIVS)

Varicose Veins | Venous Thromboembolism

Russian Federation
Shanghai Kechow Pharma, Inc.

Recruiting

Study of HL-085 and Vemurafinib in Metastatic Colorectal Cancer (mCRC) (mCRC)

CRC

China
University of Pittsburgh

Recruiting

Early Intervention for Youth at High Risk for Bipolar Disorder (KEY)

Bipolar Disorder

United States
Assistance Publique - Hôpitaux de Paris

Completed

Compensation Mechanisms in Parkinson's Disease (DATACOMT)

Parkinson Disease

France
Hanlim Pharm. Co., Ltd.

Completed

Study to Evaluate HL-TOF Tab. 5 mg Compared With XelJanz Tab. in Healthy Volunteers

Healthy Volunteers

Korea, Republic of
Faculty Hospital Kralovske Vinohrady

Not yet recruiting

Efficacy of Platelet-Rich Plasma Versus Mesotherapy in Androgenetic Alopecia: A Retrospective Study

Androgenetic Alopecia | Alopecia | Hair Loss
Ankara University

Completed

Peritonsillar Infiltration With Levobupivacaine for Posttonsillectomy Pain

Pain
National Cancer Institute (NCI)

Completed

Bortezomib and Flavopiridol in Treating Patients With Recurrent or Refractory Indolent B-Cell Neoplasms

Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma and other conditions

United States
Hanlim Pharm. Co., Ltd.

Completed

A Clinical Trial to Evaluate the Efficacy and Safety of Pitavastatin/Fenofibrate in Complex-dyslipidemia

Complex-dyslipidemia
National Cancer Institute (NCI)

Completed

Lenalidomide and Alvocidib in Treating Patients With Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Anemia | Thrombocytopenia | Chronic Lymphocytic Leukemia | Recurrent Small Lymphocytic Lymphoma | Prolymphocytic Leukemia | Refractory Chronic Lymphocytic Leukemia

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Withdrawn

Alvocidib in Combination With Decitabine and Venetoclax in Patients With Relapsed or Refractory AML or as Frontline Therapy in Unfit Patients With AML

Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia

United States
National Cancer Institute (NCI)

Terminated

Cyclophosphamide, Alvocidib, and Rituximab in Treating Patients With High Risk B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Chronic Lymphocytic Leukemia | Recurrent Small Lymphocytic Lymphoma | Prolymphocytic Leukemia | Refractory Chronic Lymphocytic Leukemia | Stage III Small Lymphocytic Lymphoma | Stage IV Small Lymphocytic Lymphoma | Stage I Chronic Lymphocytic Leukemia | Stage II Chronic Lymphocytic Leukemia | Stage... and other conditions

United States
National Cancer Institute (NCI)

Completed

Alvocidib and Oxaliplatin With or Without Fluorouracil and Leucovorin Calcium in Treating Patients With Relapsed or Refractory Germ Cell Tumors

Stage IV Ovarian Germ Cell Tumor | Recurrent Ovarian Germ Cell Tumor | Stage III Testicular Cancer | Recurrent Malignant Testicular Germ Cell Tumor | Recurrent Extragonadal Seminoma | Recurrent Malignant Extragonadal Germ Cell Tumor | Recurrent Malignant Extragonadal Non-Seminomatous Germ Cell... and other conditions

United States

Search clinical trials for: HL-040XC

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mongolia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations